Home / Inspections / 1056813

FDA Inspection 1056813 — AbbVie Bioresearch Center

AbbVie Bioresearch Center — FEI 3003684386

The FDA completed an inspection of AbbVie Bioresearch Center on May 24, 2018 in Worcester, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Worcester, MA (United States)

Facility

Other inspections at this facility

  • 1272372 (NAI Fri Sep 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1113080 (NAI Mon Nov 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1010336 (NAI Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 972163 (VAI Wed Apr 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 935478 (VAI Thu Jun 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources